portfolio
-
Early disease detection
The company's technology quantifies, digitises, simulates human physiology, and uses machine learning to increase the predictive accuracy of the diagnostic tests, thereby enabling patients to get accurate treatment.
Co-investors
-
Reducing agricultural waste
Developer of an analytics engine that learns as it maps the living soil designed to help agricultural industry professionals including agronomists and growers maximise the value of every acre. text goes here
Co-investors
Illumina
-
Get the latest science news
Sparrho (now Sparrow) combines human and artificial intelligence to help you stay on top of the science that matters to you.Co-investor
Outsized Ventures
-
Tailored biomarker tests
Inoviv develops tailored biomarker tests to identify patients and demonstrate treatment efficacy for novel therapies.
Co-investors
Hoxton Ventures, Ada Ventures
-
Genomic Medicines
Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.
Co-investors
Hoxton Ventures, Khosla Ventures, Backed
-
Therapeutics for incurable diseases
Developer of next-generation protein-based therapeutics using a machine learning-driven evolution engine.
Co-investors
Lux Capital, Atomico, Obvious Ventures, Kindred, Backed
-
Reducing waste and maintenance costs for renewable energy
Developer of a computer vision technology designed to be used in fully autonomous multi-mission on-site drones.
Co-investors
-
Facial Analysis
Facesoft uses deep learning to drive industry-leading face analysis and generation.
Co-investors
Outsized Ventures*This company has been acquired by a major tech company
-
mRNA gives scientists superpowers
HelixNano develops mRNA therapeutics designed to treat Covid-19 variants, cancer, and other diseases. The company uses artificial intelligence to leverage synthetic biology to safely and reliably express trans-genes in humans for next-generation gene therapies, genome engineering, and beyond, allowing clinicians to treat patients suffering from CoVid-19.
Co-investors
Breakthrough Energy Ventures, DCVC, Fifty Years, Starlight Ventures, Sam Altman
-
Milk Proteins
Nutropy produces milk proteins identical to those found in cow's milk to create premium French cheeses that taste as good as conventional ones while supporting the environment, animal welfare, and human health. They harness the power of cultures to improve their products.
-
Baseimmune is a biotech startup.
Founded to create the next generation of broad-spectrum vaccines against highly variable pathogens, including SARS-CoV-2.
Co-investors
-
Audio AI
Sonalytic researches and develops state-of-the-art machine learning techniques for the identification, monitoring, and discovery of music.
*Sonalytic has been acquired by Spotify
-
Connected Packaging
Scantrust is a B2B SaaS company that delivers mobile authentication and secure, unit-level traceability for the supply chain.
-
Pushing the boundaries of machine-learning
Cogitat uses AI to read brain waves and convert them into digital commands. Their hardware-agnostic software pushes the boundaries of machine learning to fully unlock the power of next-gen brain-computer interfaces.
Co-investors
The Creator Fund
-
Producer of lab-grown meat products
Designed to address climate change, food shortages and animal welfare. The company's products are made using cell culture techniques where a small sample of animal cells will be expanded by feeding these cells, enabling people to get access to eco-friendly, healthy and animal-friendly meat products.
Co-investors
Apollo Projects
-
Healthcare AI
Knowtions is building 'Lydia', an AI expert that's learning to optimise healthcare.
Co-investors
-
Diagnostic Products
Senzo is bringing fast, accurate, and cost-effective diagnostic products to the point of care.
Co-investors
Jack Selby (Thiel Capital)